Licensees

IMPORTANT NOTICE:Are Your Prescription Forms Compliant?

Effective January 1, 2021: New Prescribing and Reporting Rules for Controlled Substances

• CURES

  Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021.

  Starting January 1, 2021, new laws will impact licensees who prescribe and/or furnish controlled substances.

  1. Updated Prescription Pad Security Requirements – starting January 1, 2021, California state law requires 15 security elements to appear on California Security Prescription Forms, the forms which replaced the triplicate prescription form. State law also requires California Security Prescription Forms to be produced by printers licensed by the California Department of Justice: California Security Prescription Printers Program. For more information, visit: www.pmbc.ca.gov
  2. Revised Reporting Requirements for Controlled Substances – starting January 1, 2021, the dispensing of a controlled substance must be reported to the Controlled Substance Utilization Review and Evaluation System (CURES) within one working day after the medication is released to the patient or the patient's representative. Previously, the deadline to report was seven days after dispensing. Further, this law requires reporting of Schedule V drugs, in addition to Schedules II, III, and IV. This requirement applies to pharmacists and prescribers who dispense controlled substances.

• Doctor of Podiatric Medicine (DPM)

  • License Renewal

    • Renewal Form (Continuing Competence Certification)
    • Inactive Status License Renewal Application
    • Continuing Competence Waiver Application
    • Info. for Licensees on Continuing Competence
    • Information on Continuing Competence

  • Continuing Medical Education (CME)

    • Continuing Medical Education Programs

  • Retired

    • Retirement Renewal Fee Waiver Application

  • Disabled

    • Disability Renewal Fee Waiver Application

  • Military

    • Info for Military Personnel
    • Military Renewal Fee Waiver Application

  • Other Resources

    • Fee Schedule

• Resident

  • Licensing Application Checklist

  Forms

  • P7 – M.O.U. for Approved Residency Program Participation
  • P7 – M.O.U. for "Candidate Status" Residency Program Participation

• Fictitious Name Permit (FNP)

  The purpose of a fictitious name permit (FNP) is to allow a licensed physician and surgeon or doctor of podiatric medicine to practice under a name other than his or her own. Business and Professions Code section 2285 states: "The use of any fictitious, false, or assumed name, or any name other than his or her own by a licensee either alone, in conjunction with a partnership or group, or as the name of a professional corporation, in any public communication, advertisement, sign, or announcement of his or her practice without a fictitious–name permit obtained pursuant to Section 2415 constitutes unprofessional conduct."

  Applications for fictitious name permits are reviewed in date–received order, with an approximate processing time of four to six weeks. After review, the permit is approved or a letter of deficiency is mailed to the applicant explaining the specific problems. The Medical Board closely monitors fictitious names to ensure that similar names are not issued. If there is a name discrepancy, the FNP coordinators will work directly with the applicant, either by phone, fax, or e–mail, to agree upon an alternative name. If an application is received without payment of the $70 processing fee made out to the Medical Board of California, it will immediately be returned to the applicant.

  For further questions, call the Licensing Program at (916) 263–2382 or (800) 633–2322.

  • Name Search for Fictitious Name Permit
  • Frequently Asked Questions – Fictitious Name Permit
  • Common Reasons for Rejection of Fictitious Name Permits
  • Application for Cancellation of a Fictitious Name Permit – Fill-In
  • Fictitious Name Permit Application – Fill–In
  • Fictitious Name Permit – Change of Address Form – Fill-In
  • Fictitious Name Permit – Notification of Renewal/Hold Release – Fill-In
  • Fictitious Name Permit – Notification of Partnership Change – Fill-In
  • Fictitious Name Permit – Notification of Shareholder Change – Fill-In
  • Application for a Duplicate Fictitious Name Permit – Fill-In

• Fact Sheets

  • Careers in Podiatric Medicine
  • Important Numbers & Addresses
  • Information on Advertising
  • Information for Consumers
  • Information for Consumers – Spanish
  • Information on Continuing Competence
  • Information on The Diabetic Foot – English
  • Information on The Diabetic Foot – Spanish
  • Information on Enforcement
  • Discrimination by Health Facilities
  • Information for Health Facilities
  • Information for Individuals Wishing to Serve on BPM
  • Medical Record Retention
  • Information on Scope of Practice
  • Information for Students
  • Summary of Licensing Requirements & Important Information
  • You and Your DPM (brochure)
  • Orthotics Can Help (brochure)
  • Orthotics Can Help (brochure) – Spanish
  • Diabetics: Keep an eye on your feet (brochure)
  • Diabetics: Keep an eye on your feet (brochure) – Spanish

• DPMs & Histories & Physicals

  • Memo from DCA Legal Office:
    • Histories & Physical Examinations
  • CMS Medicare & Medicaid Programs; Conditions of Participation
  • Office of the Attorney General:
    Indexed Opinion No. 09–0504 – Histories & Physicals

• Name and Gender Change Notification and Request for Confidentiality (SB 372, 2023)

  Effective January 1, 2024, under Business and Professions Code section 27.5, licensees may notify the licensing board or bureau within the Department of Consumer Affairs (DCA) of a name and/or gender change and request confidentiality of the previous name or gender information, when meeting certain specified requirements. For more information and to make a request, click here.